OnKure Therapeutics, Inc. Class A (OKUR)
NASDAQ · Manufacturing · Pharmaceutical preparations
$2.91−$0.0200 (−0.68%) on the dayAs of the close; data may be delayed.
OKUR price, last 12 months
Key stats
- Previous close
- $2.93
- Open
- $2.93
- Day range
- $2.86 – $3.00
- 52-week range
- $2.23 – $5.38
- Volume
- 72.1K
- Avg volume (20 days)
- 163.6K
- Market cap
- $117.4M
Performance
1W−1.4%
1M−23.4%
3M−35.3%
6M−36.6%
YTD+0.3%
1Y+11.9%
vs S&P 500, 1Y−4.9 pts
Technicals and fundamentals
About OnKure Therapeutics, Inc. Class A
OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing precision medicines that target biologically validated drivers of cancers underserved by available therapies. The company uses a structure-based drug design platform to develop a pipeline of drug candidates aimed at optimizing efficacy and tolerability. The company has multiple programs focused on targeting oncogenic PI3Kα. Its flagship program is OKI-219. The company operates in one operating segment: clinical research.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $117.4M